Permeability of 5-fluorouracil and prodrugs in Caco-2 cell monolayers.

被引:31
作者
Buur, A
Trier, L
Magnusson, C
Artursson, P
机构
[1] UNIV UPPSALA,BMC,DEPT PHARMACEUT,S-75123 UPPSALA,SWEDEN
[2] ROYAL DANISH SCH PHARM,DEPT PHARMACEUT CHEM,DK-2100 COPENHAGEN,DENMARK
关键词
5-fluorouracil; Caco-2; monolayers; prodrugs; toxicity; permeability; drug absorption;
D O I
10.1016/0378-5173(95)04331-4
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The toxicity and permeability of 5-fluorouracil (5FU) and 13 5FU prodrugs was investigated in Caco-2 monolayers grown on permeable supports. Only one of the prodrugs (VII) was toxic to the cell monolayers at 1 x 10(-4) M, as assessed by an increased permeability of the cell monolayers to the hydrophilic probe C-14-mannitol. The monolayer integrity was restored after a 4-fold reduction in the concentration of this prodrug. The permeabilities of 5FU and prodrugs increased roughly with the apparent partition coefficients (P-octanol-buffer) (r = 0.74). Attempts to correlate the permeabilities with other single physicochemical parameters such as hydrogen-bonding capacity and solubility resulted in poorer correlations. A slightly better relationship was obtained when the permeability was correlated with the two physicochemical parameters (P-octanol-buffer) and aqueous solubility by multiple linear regression analysis (r = 0.81). The ranking of the permeabilities of four of the compounds previously studied in rabbit colon and rectum was comparable in the cell monolayers and in the intestinal segments. These results indicate that Caco-2 monolayers can be used to predict drug absorption, not only of conventional drugs but also of small prodrugs such as those used here.
引用
收藏
页码:223 / 231
页数:9
相关论文
共 28 条
[11]  
BUUR A, 1986, INT J PHARM, V75, P676
[12]  
BUUR A, 1986, ARCH PHARM CHEMI SCI, V14, P99
[13]   FLUOROURACIL THERAPY IN PATIENTS WITH CARCINOMA OF LARGE BOWEL - PHARMACOKINETIC COMPARISON OF VARIOUS RATES AND ROUTES OF ADMINISTRATION [J].
CHRISTOPHIDIS, N ;
VAJDA, FJE ;
LUCAS, I ;
DRUMMER, O ;
MOON, WJ ;
LOUIS, WJ .
CLINICAL PHARMACOKINETICS, 1978, 3 (04) :330-336
[14]  
COHEN JL, 1974, CANCER CHEMOTH REP 1, V58, P723
[15]   THE INFLUENCE OF PEPTIDE STRUCTURE ON TRANSPORT ACROSS CACO-2 CELLS [J].
CONRADI, RA ;
HILGERS, AR ;
HO, NFH ;
BURTON, PS .
PHARMACEUTICAL RESEARCH, 1991, 8 (12) :1453-1460
[16]   DRUG-DELIVERY STUDIES IN CACO-2 MONOLAYERS - SYNTHESIS, HYDROLYSIS, AND TRANSPORT OF O-CYCLOPROPANE CARBOXYLIC-ACID ESTER PRODRUGS OF VARIOUS BETA-BLOCKING-AGENTS [J].
HOVGAARD, L ;
BRONDSTED, H ;
BUUR, A ;
BUNDGAARD, H .
PHARMACEUTICAL RESEARCH, 1995, 12 (03) :387-392
[17]  
INUI K, 1992, J PHARMACOL EXP THER, V261, P195
[18]   TRANSPORT OF CELIPROLOL ACROSS HUMAN INTESTINAL EPITHELIAL (CACO-2) CELLS - MEDIATION OF SECRETION BY MULTIPLE TRANSPORTERS INCLUDING P-GLYCOPROTEIN [J].
KARLSSON, J ;
KUO, SM ;
ZIEMNIAK, J ;
ARTURSSON, P .
BRITISH JOURNAL OF PHARMACOLOGY, 1993, 110 (03) :1009-1016
[19]   A METHOD FOR THE DETERMINATION OF CELLULAR PERMEABILITY COEFFICIENTS AND AQUEOUS BOUNDARY-LAYER THICKNESS IN MONOLAYERS OF INTESTINAL EPITHELIAL (CACO-2) CELLS GROWN IN PERMEABLE FILTER CHAMBERS [J].
KARLSSON, J ;
ARTURSSON, P .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1991, 71 (1-2) :55-64
[20]  
KIM DC, 1993, PHARMACEUT RES, V10, P12